These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. DMARDs in the treatment of rheumatoid arthritis: current agents and future developments. Simon LS. Int J Clin Pract; 2000 May; 54(4):243-9. PubMed ID: 10912314 [Abstract] [Full Text] [Related]
3. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists. van Roon EN, van den Bemt PM, Jansen TL, Houtman NM, van de Laar MA, Brouwers JR. Clin Ther; 2009 Aug; 31(8):1737-46. PubMed ID: 19808132 [Abstract] [Full Text] [Related]
13. Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Hyrich KL, Symmons DP, Watson KD, Silman AJ, British Society for Rheumatology Biologics Register. Arthritis Rheum; 2006 Jun; 54(6):1786-94. PubMed ID: 16736520 [Abstract] [Full Text] [Related]
14. Prescribing trends in disease modifying antirheumatic drugs for rheumatoid arthritis: a survey of practicing Canadian rheumatologists. Pope JE, Hong P, Koehler BE. J Rheumatol; 2002 Feb; 29(2):255-60. PubMed ID: 11838842 [Abstract] [Full Text] [Related]
15. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial. Rantalaiho V, Korpela M, Hannonen P, Kautiainen H, Järvenpää S, Leirisalo-Repo M, Hakala M, Puolakka K, Julkunen H, Luosujärvi R, Möttönen T, FIN-RACo Trial Group. Arthritis Rheum; 2009 May; 60(5):1222-31. PubMed ID: 19404945 [Abstract] [Full Text] [Related]
16. Assessment of adherence to and persistence on disease-modifying antirheumatic drugs (DMARDs) in patients with rheumatoid arthritis. Grijalva CG, Chung CP, Arbogast PG, Stein CM, Mitchel EF, Griffin MR. Med Care; 2007 Oct; 45(10 Supl 2):S66-76. PubMed ID: 17909386 [Abstract] [Full Text] [Related]